Sonophoto-activable artificial cupreous peroxidases for controllable and redox-targeted ablation of primary and metastatic cancers
Cell Biomaterials · 2026-10 · 2 (10) · 100348
DOI: 10.1016/j.celbio.2026.100348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biomaterials, 2026-10. Verfasst von Ruiqian Guo und 11 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Support Program, Key Technologies Research and Development Program, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Sichuan Province Science and Technology Support Program
- Key Technologies Research and Development Program
- China Postdoctoral Science Foundation
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Sichuan University
Zitieren
APA
Guo, R., Xiao, S., Wang, M., Geng, W., Feng, Z., Xiang, X., Wang, X., Adeli, M., Li, S., Cheng, C., Qiu, L., & Zhao, C. (2026). Sonophoto-activable artificial cupreous peroxidases for controllable and redox-targeted ablation of primary and metastatic cancers. Cell Biomaterials, 2(10), 100348. https://doi.org/10.1016/j.celbio.2026.100348
Vancouver
Guo R, Xiao S, Wang M, Geng W, Feng Z, Xiang X, et al. Sonophoto-activable artificial cupreous peroxidases for controllable and redox-targeted ablation of primary and metastatic cancers. Cell Biomaterials. 2026;2(10):100348. doi:10.1016/j.celbio.2026.100348
BibTeX
@article{Guo2026,
author = {Guo, Ruiqian and Xiao, Sutong and Wang, Mao and Geng, Wei and Feng, Ziyan and Xiang, Xi and Wang, Xiaolin and Adeli, Mohsen and Li, Shuang and Cheng, Chong and Qiu, Li and Zhao, Changsheng},
title = {Sonophoto-activable artificial cupreous peroxidases for controllable and redox-targeted ablation of primary and metastatic cancers},
journal = {Cell Biomaterials},
year = {2026},
volume = {2},
number = {10},
pages = {100348},
doi = {10.1016/j.celbio.2026.100348}
}
EUVIMED